Nucleus Financial Gp - Director/PDMR Shareholding
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN, INTO OR FROM ANY RESTRICTED JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF SUCH JURISDICTION.
FOR IMMEDIATE RELEASE.
RECOMMENDED CASH OFFER
for
Nucleus Financial Group plc
("Nucleus" or the "Company")
by
James Hay Holdings Limited
(an indirect wholly owned subsidiary of IFG Group Limited, the parent company of the James Hay Group)
Director/PDMR shareholding, allotment of shares to employee benefit trust and statement of Total Voting Rights
1. Director/PDMR Shareholding
Nucleus (AIM: NUC) announces that, on
Each of these exercises:
· was in accordance with proposals made by James Hay Holdings Limited ("James Hay Holdings") to participants in the LTIP under Rule 15 of the Code (the "Rule 15 Proposals") in connection with its recommended cash offer (the "Offer") to acquire the entire issued and to be issued ordinary share capital of the Company; and
· became effective shortly after the Offer was declared unconditional in all respects (as stated by James Hay Holdings in its announcement this morning).
|
PDMR |
Role |
Aggregate number of Shares acquired on |
|
|
Chief Executive Officer |
235,050 |
|
|
Chief Finance Officer |
165,139 |
|
|
Chief Customer Officer |
92,597 |
|
|
Chief Technology Officer |
91,593 |
|
|
|
71,390 |
The Shares required to satisfy the above exercises (which, in accordance with the terms of the Rule 15 Proposals, will in due course be assented to the Offer) are being sourced from the NFG Limited Employee Benefit Trust 2010 (the "EBT") - see below for further information.
2. Allotment of shares to employee benefit trust and statement of Total Voting Rights
Nucleus also announces that, in order to facilitate the satisfaction of the Rule 15 Proposals made by James Hay Holdings (including the above noted exercises of nil-cost options by PDMRs), it has allotted 452,543 new Shares (the "New Ordinary Shares") to the trustee of the EBT. Following this allotment, the EBT's total holding will comprise 992,543 Shares.
It is anticipated that the New Ordinary Shares (which will rank pari passu in all respects with the existing ordinary shares of the Company) will be admitted to trading on AIM on or around
The following notifications are intended to satisfy the Company's obligations under Article 19(3) of EU Regulation No 596/2014 (the Market Abuse Regulation).
Notification of transactions of persons discharging managerial responsibilities and persons closely associated with them
|
1
|
Details of the person discharging managerial responsibilities / person closely associated
|
|||||||||||||||||||
|
a)
|
Name
|
1. 2. 3. 4. 5. |
||||||||||||||||||
|
2
|
Reason for the notification
|
|||||||||||||||||||
|
a)
|
Position/status
|
1. Chief Executive Officer 2. Chief Finance Officer 3. Chief Customer Officer 4. Chief Technology Officer 5. |
||||||||||||||||||
|
b)
|
Initial notification /Amendment
|
Initial Notification |
||||||||||||||||||
|
3
|
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
|
|||||||||||||||||||
|
a)
|
Name
|
Nucleus Financial Group plc |
||||||||||||||||||
|
b)
|
LEI
|
213800MAIAI3M7LM5950 |
||||||||||||||||||
|
4
|
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
|
|||||||||||||||||||
|
a)
|
Description of the financial instrument, type of instrument
Identification code
|
Ordinary shares of
GB00BG226J60 |
||||||||||||||||||
|
b)
|
Nature of the transaction
|
Acquisition of Shares on the exercise of awards (in the form of nil-cost options) pursuant to the Nucleus Financial Group plc Long Term Incentive Plan
|
||||||||||||||||||
|
c)
|
Price(s) and volume(s)
|
|
||||||||||||||||||
|
d)
|
Aggregated information
-Aggregated volume
- Price
|
1. N/A single transaction 2. N/A single transaction 3. N/A single transaction 4. N/A single transaction 5. N/A single transaction |
||||||||||||||||||
|
e)
|
Date of the transaction
|
|
||||||||||||||||||
|
f)
|
Place of the transaction
|
Outside a trading venue |
||||||||||||||||||
For further information please contact:
|
James Hay enquiries Fenchurch Advisory Partners LLP (Financial Adviser to the James Hay Group) |
|
|
|
|
|
TB Cardew (PR Adviser to the James Hay Group) |
|
|
|
+44 (0) 7789 998020 +44 (0) 7775 848537 |
|
Nucleus enquiries Nucleus Financial Group plc |
+44 (0)131 226 9800 |
|
Investor Enquiries Shore Capital (Joint Financial and Rule 3 Adviser, Nominated Adviser and Corporate Broker to Nucleus) |
+44 (0) 20 7408 4090 |
|
Craven Street Capital (Joint Financial and Rule 3 Adviser to Nucleus) Soondra Appavoo |
+44 (0) 20 3890 8654 |
|
Media Enquiries Camarco (PR Adviser to Nucleus) |
+44 (0) 20 3757 4994 |
Further Information
This announcement is for information purposes only and is not intended to and does not constitute or form part of an offer, invitation or the solicitation of an offer or invitation to purchase, or otherwise acquire, subscribe for, sell or otherwise dispose of any securities or the solicitation of any vote or approval in any jurisdiction pursuant to the Acquisition or otherwise, nor shall there be any sale, issuance or transfer of securities of Nucleus pursuant to the Acquisition in any jurisdiction in contravention of applicable laws. The Acquisition will be implemented solely pursuant to the terms of the Offer Document, which contains the full terms and conditions of the Offer, including details of how to accept the Offer. Any decision in respect of, or other response to, the Offer should be made on the basis of the information contained in the Offer Document.
Nucleus and James Hay Holdings urge Nucleus Shareholders to read the Offer Document carefully, as it contains important information in relation to the Offer.
This announcement does not constitute a prospectus or prospectus equivalent document.
Important Notices Relating to Financial Advisers
Shore Capital & Corporate Limited and Shore Capital Stockbrokers Limited (either individually or collectively "Shore Capital") which are authorised and regulated by the Financial Conduct Authority in the
Craven Street Capital, an appointed representative of Resolution Compliance Limited which is authorised and regulated by the FCA in the
Fenchurch Advisory Partners LLP, which is authorised and regulated by the FCA in the
Publication on website and availability of hard copies
A copy of this announcement and certain other documentation in connection with the Offer, are and will be available, subject to certain restrictions relating to persons resident in Restricted Jurisdictions, for inspection on James Hay's website (www.jameshay.co.uk) and on Nucleus' website (www.nucleusfinancial.com/investors) by no later than 12 noon (
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Proactive Investors is a publisher of financial news and information. No content in this record, or published on the Proactive Investors website (the "Site"), constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is suitable or advisable for any specific person. No content is tailored to any specific person's needs, objectives, or financial situation.
Proactive Investors is not a registered investment adviser or broker-dealer and does not provide personalized investment advice. Nothing in this record constitutes investment advice or a recommendation to buy, hold, or sell any security. None of the information providers or their affiliates will advise you personally concerning the nature, potential, advisability, value, or suitability of any particular security, portfolio, transaction, or investment strategy. Any decision to buy, sell, or hold a security should be made only after consulting an appropriately qualified, licensed financial adviser and reading all relevant offering documentation.
This record, and any record we publish by or on behalf of our clients, should not be construed as an offer or solicitation to buy or sell any product or security. Our content is independent financial journalism, produced in a neutral, objective style with full source attribution.
In accordance with the Federal Trade Commission's guidelines on material connections, Proactive Investors discloses the following: we may receive cash or, in some cases, equity compensation from companies whose news is distributed through our platform. This compensation is for news distribution and media services, not for editorial content or coverage decisions. Where Proactive Investors has a commercial relationship with a company covered in this record, that relationship is disclosed within the article. Any such relationship does not determine, influence, or shape the editorial content produced. Where we receive equity compensation, such securities are held independently by a third-party broker and sold at the broker's discretion.
The Site may contain opinions from time to time regarding securities mentioned in other products, including company-related products, and those opinions may differ from those obtained through another Proactive Investors product. Opinions and commentary reflect the views of the named author at the time of writing and are subject to change without notice.
Price and other data is supplied by sources believed to be reliable. Any calculations are made using such data. Neither the data nor the calculations are guaranteed by those sources, by Proactive Investors, by the information providers, or by any other person or entity, and may not be complete or accurate.
From time to time, reference may be made in our marketing materials to previously published articles or opinions. Such references may be selective, may reference only a portion of an article, and are likely not to be current. As markets change continuously, previously published information and data may not be current and should not be relied upon.
FOR OUR FULL DISCLAIMER CLICK HERE